Viewing Study NCT01770834


Ignite Creation Date: 2025-12-25 @ 2:22 AM
Ignite Modification Date: 2026-03-05 @ 9:41 AM
Study NCT ID: NCT01770834
Status: COMPLETED
Last Update Posted: 2018-03-02
First Post: 2013-01-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Prospective, Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
Sponsor: Hoffmann-La Roche
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module